kb2145 (Krishgen Biosystems)
Krishgen Biosystems is a verified supplier 
Krishgen Biosystems manufactures this product 
94
Structured Review
Krishgen Biosystems
kb2145
Kb2145, supplied by Krishgen Biosystems, used in various techniques. Bioz Stars score: 94/100, based on 94 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kb2145/GENLISA+Mouse+Tumor+Necrosis+Factor+Alpha+(TNF-A+%2F+TNFA)+ELISA/10__1186_slash_s41936___026___00580___8-77-35-46
Average 94 stars, based on 94 article reviews
Kb2145, supplied by Krishgen Biosystems, used in various techniques. Bioz Stars score: 94/100, based on 94 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kb2145/GENLISA+Mouse+Tumor+Necrosis+Factor+Alpha+(TNF-A+%2F+TNFA)+ELISA/10__1186_slash_s41936___026___00580___8-77-35-46
Average 94 stars, based on 94 article reviews
kb2145 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
other:Article Title: Teriflunomide mitigates pain-depression dyad in mice: Modulation of PI3K-mediated defensive signaling Article Snippet: No. Enzyme-linked Immunosorbent Assay:Article Title: Andrographolide mitigates lipopolysaccharide-induced mastitis in a mouse model: role of oxidative stress, inflammation, and mitochondrial dysfunction Article Snippet: Estimation of signalling/transcription factor in mammary homogenate Signalling factor (NF-κB) (catalogue no.-KBH11868) in tissue homogenates was estimated using commercially available ELISA kits (Krishgen biosystem, USA). .. Estimation of inflammatory cytokines in mammary homogenate and serum Mammary tissue homogenates and corresponding serum samples were used for inflammatory cytokine estimation using a commercially available ELISA kit [Tumor necrosis factor alpha (TNF-α), catalogue no.- Article Title: Loss of Protection by Antiepileptic Drugs in Lipopolysaccharide-primed Pilocarpine-induced Status Epilepticus is Mediated via Inflammatory Signalling. Article Snippet: The evidences from various studies show the association of peripheral and neuronal inflammation with complex pathophysiology of status epilepticus (SE).. In this view, the present work attempted to develop a model of neuronal inflammation mediated SE by combining both epileptic and inflammatory components of the disease and also to mimic SE co-morbid with systemic inflammation by peripheral administration of the lipopolysaccharide (LPS) 2 hours prior to the pilocarpine induction in C57BL/6 mice.. We evaluated the anticonvulsant and neuroprotective effects of 7-day prophylactic treatment with three conventional anti-epileptic drugs (Sodium valproate, SVP 300 mg/kg p.o.; Carbamazepine CBZ 100 mg/kg p.o.; Levetiracetam; LEV 200 mg/kg p.o.) of widespread clinical use. In Vivo:Article Title: Loss of Protection by Antiepileptic Drugs in Lipopolysaccharide-primed Pilocarpine-induced Status Epilepticus is Mediated via Inflammatory Signalling. Article Snippet: The evidences from various studies show the association of peripheral and neuronal inflammation with complex pathophysiology of status epilepticus (SE).. In this view, the present work attempted to develop a model of neuronal inflammation mediated SE by combining both epileptic and inflammatory components of the disease and also to mimic SE co-morbid with systemic inflammation by peripheral administration of the lipopolysaccharide (LPS) 2 hours prior to the pilocarpine induction in C57BL/6 mice.. We evaluated the anticonvulsant and neuroprotective effects of 7-day prophylactic treatment with three conventional anti-epileptic drugs (Sodium valproate, SVP 300 mg/kg p.o.; Carbamazepine CBZ 100 mg/kg p.o.; Levetiracetam; LEV 200 mg/kg p.o.) of widespread clinical use. |
